Priority Date: 16.06.16 (US 201662351234P)

TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT

  • Application ID: EP17814223
  • Status: Examination is in progress

Attorney

Employment test 11 - 50 employees
Company dna eip1
operating since 2009
1190.17
Headquarter in London and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 174 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 16.06.2016 - Priority Date (US 201662351234P)
  • 21.12.2017 - Publication A2 (WO2017218974)
  • 24.04.2019 - Publication A2 (EP3471780)